FeesSafety
Pluang+

Evotec secures $2.9M Gates Foundation grant to extend fetal safety drug testing platform for 3 more years

Market News
16 Nov 2026, 08:57 WIB
PRNewsWire
View Source
Bullish
Evotec secures $2.9M Gates Foundation grant to extend fetal safety drug testing platform for 3 more years

Evotec SE received a $2.9 million grant from the Gates Foundation to continue its project using human stem cell-based methods to identify fetal development risks in new drug candidates. This three-year extension builds on a 2023 initiative, helping researchers screen potential drug safety issues earlier and reduce costly late-stage failures. Evotec's platform uses human induced pluripotent stem cells combined with large-scale screening to generate relevant safety data, supporting global health research and reducing reliance on animal testing. The ongoing collaboration highlights Evotec's advanced drug discovery capabilities and commitment to improving drug safety assessment worldwide.

Evotec's ongoing drug safety testing project is supported by a $2.9 million grant from the Gates Foundation. For readers following health-sector stocks, here is Pluang's market snapshot as of Nov 16, 2026 12:41 WIB: out of 150 priced US health stocks, 48 rose and 99 fell. Notable movers include FLNA at USD 0.43 with a -10.81% change and a typical hold time of 39 days, NUWE at USD 5.02 down 9.22%, and IBRX at USD 6.07 down 9.00% with a 4-day hold time.

More News

Jyske Bank buys back shares worth DKK 2.39 billion, holding 4.22% treasury shares as of November 2026

Jyske Bank buys back shares worth DKK 2.39 billion, holding 4.22% treasury shares as of November 2026

Jyske Bank has been actively repurchasing its shares under a program running from February 2026 to January 2027, acquiring shares worth up to DKK 3 billion. As of mid-November 2026, the bank has bought back shares valued at approximately DKK 2.39 bil...

Company Fundamentals
Neutral
1 hour ago
Jyske Bank buys back 2.45M shares worth DKK 2.39B, owning 4.22% of its stock by Nov 2026.

Jyske Bank buys back 2.45M shares worth DKK 2.39B, owning 4.22% of its stock by Nov 2026.

Jyske Bank is conducting a share buyback program running from February 5, 2026, to January 29, 2027, with a maximum value of DKK 3 billion. As of mid-November 2026, the bank has repurchased 2,453,745 shares at an average price of DKK 974.50 per share...

Company Fundamentals
Bullish
1 hour ago
Chinese beauty innovation shines at 2026 INPD in Paris with OSM winning top RMB 1M award

Chinese beauty innovation shines at 2026 INPD in Paris with OSM winning top RMB 1M award

The 2026 International Cosmetics Innovation Summit and Awards (INPD) was held in Paris, showcasing Chinese beauty companies' innovations under the theme "REGENERATIONS." Sixteen Chinese brands received awards for breakthroughs in ingredients, formula...

Bullish
2 hours ago
OrdoAI launches Ordo Brand AI tool to streamline global marketing with creator partnerships, public release in Q1 2027.

OrdoAI launches Ordo Brand AI tool to streamline global marketing with creator partnerships, public release in Q1 2027.

OrdoAI, a company specializing in AI-driven global marketing, is expanding into AI product development with its first AI agent, Ordo Brand. This tool helps brands and agencies manage creator partnerships across markets by simplifying discovery, outre...

Others
Bullish
2 hours ago
Ethereum's EIP-8037 to raise gas costs for new accounts and contracts, sparking developer debate.

Ethereum's EIP-8037 to raise gas costs for new accounts and contracts, sparking developer debate.

Ethereum co-founder Vitalik Buterin supports EIP-8037, a proposal to increase gas fees for creating new accounts, storage slots, and smart contracts to control Ethereum's state growth and improve scaling. The upgrade introduces a state-gas reservoir ...

Protocol Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App